276 results on '"Altman, Douglas G"'
Search Results
2. The STROBE Extensions: Considerations for Development
3. Statistics Notes: Percentage differences, symmetry, and natural logarithms
4. Statistics Notes: What is a percentage difference?
5. Population attributable fraction
6. Statistics Notes: Percentage differences, symmetry, and natural logarithms
7. Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials—ESORT)
8. The INTERGROWTH-21st fetal growth standards: toward the global integration of pregnancy and pediatric care
9. Guidelines for the Content of Statistical Analysis Plans in Clinical Trials
10. One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial
11. Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial†
12. Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials—ESORT)
13. International Standards for Symphysis-Fundal Height Based on Serial Measurements From the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: Prospective Cohort Study in Eight Countries
14. Harms of outcome switching in reports of randomised trials: CONSORT perspective
15. The satisfactory growth and development at 2 years of age of the INTERGROWTH-21st Fetal Growth Standards cohort support its appropriateness for constructing international standards
16. The CARE guidelines: consensus-based clinical case reporting guideline development
17. Authorsʼ reply to Cunningham and Messerli and colleagues
18. Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
19. Sparse data bias: a problem hiding in plain sight
20. Gestational weight gain standards based on women enrolled in the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: a prospective longitudinal cohort study
21. PRISMA harms checklist: improving harms reporting in systematic reviews
22. Reply to KL Stanhope and PJ Havel
23. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies
24. Inverse probability weighting
25. Best (but oft forgotten) practices: testing for treatment effects in randomized trials by separate analyses of changes from baseline in each group is a misleading approach1
26. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
27. Monitoring human growth and development: a continuum from the womb to the classroom
28. Systematic review of the methodological quality of studies designed to create neonatal anthropometric charts
29. CLINICAL TRIALS: Subgroup analyses in randomized trials—more rigour needed
30. Statistics Notes: Bootstrap resampling methods
31. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
32. The CONSORT Statement: Application within and adaptations for orthodontic trials
33. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)
34. CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration
35. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
36. Avoidable waste of research related to inadequate methods in clinical trials
37. NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
38. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
39. Association of Cardiovascular Trial Registration With Positive Study Findings: Epidemiological Study of Randomized Trials (ESORT)
40. Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials—ESORT)
41. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
42. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
43. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
44. Uncertainty and sampling error
45. Uncertainty beyond sampling error
46. Association Between Analytic Strategy and Estimates of Treatment Outcomes in Meta-analyses
47. Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study
48. Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review
49. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
50. The CARE Guidelines: Consensus-Based Clinical Case Reporting Guideline Development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.